Heart Pump Devices Market Application And Share Value Product (Ventricular Assist Devices, Intra-Aortic Balloon Pumps), Type (Implantable Heart Pump Devices), Therapy (Bridge-To-Candidacy, Destination Therapy) and By End-User – Global Forecast till 2027
Request Free Sample Report: https://www.marketresearchfuture.com/sample_request/6034
Heart pump devices market was valued at USD 1,000 million in 2017 and is expected to grow at a CAGR of 12.5% during the forecast period, 2018–2023.
Various factors are propelling the heart pump devices market growth. Some of these factors, according to the Market Research Future report, include the growing demand for surgical methods in cardiology that are minimally invasive, refining healthcare infrastructure especially in developing countries, regulatory approvals for advanced and new heart pump devices, growing elderly population, and an acute shortage of donor hearts. Additional factors pushing market growth include advancements in technology in heart pump devices, increasing utilization of ventricular assist devices for supporting blood flow and heart function in those with a weak heart, new product approvals, rising affordability, and increasing incidence of cardiovascular diseases.
On the flip side, the inclination of alternative means of drug delivery, poor reimbursement scenario, and the high price of devices are factors that may impede the heart pump devices market size and growth over the forecast period.
Heart Pump Devices Market Segmentation
The MRFR report provides an all-inclusive segmental analysis of the heart pump devices market based on end user, therapy, product, and type.
Based on type, the heart pump devices market is segmented into extracorporeal heart pump devices and implantable heart pump devices. Of these, the implantable heart pump devices will lead the market over the forecast period on account of advancements in technology in these heart pump devices which have improved their efficiency and also made them more safe and reliable, thus enabling their long-term use as survival options for those that cannot undergo heart transplants.
Based on the product, the heart pump devices market is segmented into total artificial heart, ventricular assist devices, and intra-aortic balloon pumps. The ventricular assist devices are again segmented into transcutaneous ventricular assist devices, percutaneous ventricular assist devices, bi-ventricular assist devices, left ventricular assist devices, and right ventricular assist devices. Of these, the ventricular assist devices will dominate the market over the forecast period on account of increased dependency on this device to treat heart failure coupled with advancements in technology to enhance the safety of ventricular assist devices.
Based on therapy, the heart pump devices market is segmented into destination therapy, bridge-to-transplant, bridge-to-candidacy, and others. Of these, the destination therapy will have the largest share in the market over the forecast period on account of the advancements in technology in heart pump technology for improving their efficacy and safety as well as patients’ quality of life.
Based on the end user, the heart pump devices market is segmented into research institutes, ambulatory surgical centers, hospitals and clinics, and others.
Heart Pump Devices Market Regional Analysis
By region, the heart pump devices market report covers the latest trends, share and growth opportunities across the Americas, Europe, North America, and the Middle East and Africa. Of these, the Americas will remain the driving force over the forecast period on account of increasing patient population, increasing aging population, rising cardiovascular disorder, and increasing initiatives undertaken by the government for R&D of advanced and innovative products.
The heart pump devices market in Europe is anticipated to have the second-largest share in the market during the forecast period chiefly on account of increasing obesity rates, increasing prevalence of cardiovascular disorders, rising older population, burgeoning demand for minimally invasive treatments, increasing healthcare infrastructure, and growing government support.
The heart pump devices market size in the APAC region is predicted to grow at the highest CAGR during the forecast period chiefly on account of improved living standards, rising population, demand for innovative and new treatment options, increasing healthcare spending, growing demand for diagnostic services, and rapid development of healthcare infrastructure.
The heart pump devices market in the MEA is predicted to experience slow growth over the forecast period on account of affordability issues and restricted access to healthcare facilities.
Heart Pump Devices Market Key Players
Notable players profiled in the heart pump devices industry report include Thoratec Corporation, Cardiacassist, Berlin Heart, Terumo, Reliantheart, Teleflex, Syncardia Systems, Getinge, Abiomed, Abbott, and Medtronic.
Heart Pump Devices Industry News
October 2019: Medtronic has received FDA’s breakthrough support for its latest implantable heart pump that will treat people with advanced heart failure. The LVAD (left ventricular assist device) in development can be implanted completely sans any cable line that will extend to the power source outside the human body. It can be utilized as destination therapy or bridge to heart transplants for those who are not candidates for heart transplants.
read more @ https://www.marketresearchfuture.com/reports/heart-pump-devices-market-6034
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Heart Pump Devices Market Size, Growth and Application By Product (Ventricular Assist Devices, Intra-Aortic Balloon Pumps), Type (Implantable Heart Pump Devices), Therapy (Bridge-To-Candidacy, Destination Therapy), End-User – Global Forecast Till 2023
The global Heart Pump Devices Market size is anticipated to grow at a 12.5% CAGR between 2018-2023, states the latest Market Research Future (MRFR) report.
Some of these factors, according to the Market Research Future report, include the growing demand for surgical methods in cardiology that are minimally invasive, refining healthcare infrastructure especially in developing countries, regulatory approvals for advanced and new heart pump devices, growing elderly population, and an acute shortage of donor hearts.
Additional factors pushing market growth include advancements in technology in heart pump devices, increasing utilization of ventricular assist devices for supporting blood flow and heart function in those with a weak heart, new product approvals, rising affordability, and increasing incidence of cardiovascular diseases.
Based on the end user, the heart pump devices market is segmented into research institutes, ambulatory surgical centers, hospitals and clinics, and others.
Heart Pump Devices Market Regional Analysis
Uterine Fibroid Market Information By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), By Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2027Market ScenarioMarket Research Future (MRFR) speculates that the U.S. uterine fibroid market is likely to garner USD 39,993.2 million, grabbing a CAGR of 3.24% during the forecast period (2016-2022).
Also termed as myomas or leiomyoma, uterine fibroids are non-cancerous growth which causes symptoms like pain in the pelvis and lower back, heavy bleeding during or between the menstrual cycle, and increased menstrual cramps along with the enlargement of the abdomen.Market Potential and PitfallsUterine fibroids are spreading over the entire U.S. at a rapid pace mainly due to the increased prevalence of uterine fibroids in the African-American race.
The U.S. uterine fibroid market is anticipated to touch high growth figures in the long run mainly due to the surging prevalence of uterine fibroids and the rising number of hysterectomy surgeries every year.
Several treatment options available such as pharmacotherapy, self-help techniques, invasive surgical procedures, and uterine artery embolization are propelling the market growth in the U.S.The introduction of minimally invasive surgeries such as myomectomy and hysterectomy for treating the excruciating pain of uterine fibroids is expected to encourage the market growth.
Such surgeries have reduced the chances of infection, reduced the hospital stay, and, lowered the recovery time, thereby contributing to the growth.
This has resulted in limited treatment options for uterine fibroids.
